https://www.marketscreener.com/quote/stock/OSE-IMMUNOTHERAPEUTICS-21120309/news/Ose-Immunotherapeutics-Sa-Announces-Completion-of-Enrollment-in-Phase-2-Clinical-Trial-Evaluating-Lu-46237473/?utm_source=telegram&utm_medium=social&utm_campaign=share